Skip to content
Catalyst

20-hydroxyecdysonePapers

Papers about 20-hydroxyecdysone

papers
6
5 years, by papers

Newest first

1 to 6 of 6

Every paper here, unless its row says otherwiseReturned by a PubMed search for 20-hydroxyecdysone

  • BIO101 in Sarcopenic Seniors at Risk of Mobility Disability: Results of a Double-Blind Randomised Interventional Phase 2b Trial.

    Journal of cachexia, sarcopenia and muscle2025PMID 40026058

  • Effects of Asparagus-Derived 20-Hydroxyecdysone Supplementation on Fat Oxidation and Insulin Sensitivity in Resistance-Trained Males.

    Journal of nutritional science and vitaminology2025PMID 41485968

  • Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial.

    EClinicalMedicine2024PMID 38545090

  • A Phase 1 study for safety and pharmacokinetics of BIO101 (20-hydroxyecdysone) in healthy young and older adults.

    Journal of cachexia, sarcopenia and muscle2023PMID 37057316Also measures 20-hydroxyecdysone

  • Antiprotozoal effect of steroid hormone 20-hydroxyecdysone in giardiosis patients.

    Annals of parasitology2022PMID 36617399Also tests 20-hydroxyecdysone

  • Effects of methoxyisoflavone, ecdysterone, and sulfo-polysaccharide supplementation on training adaptations in resistance-trained males.

    Journal of the International Society of Sports Nutrition2006PMID 18500969Also tests 20-hydroxyecdysone